171 related articles for article (PubMed ID: 19381892)
1. Platelet count: association with prognosis in lung cancer.
Gonzalez Barcala FJ; Garcia Prim JM; Moldes Rodriguez M; Alvarez Fernandez J; Rey Rey MJ; Pose Reino A; Valdes Cuadrado L
Med Oncol; 2010 Jun; 27(2):357-62. PubMed ID: 19381892
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of thrombocytosis in patients with primary lung cancer.
Pedersen LM; Milman N
Eur Respir J; 1996 Sep; 9(9):1826-30. PubMed ID: 8880098
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts.
Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi JW; Chun M; Oh YT; Kang S; Park KJ; Hwang SC; Lee YH; Hahn MH
Lung Cancer; 2001; 33(2-3):171-9. PubMed ID: 11551412
[TBL] [Abstract][Full Text] [Related]
4. Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer.
Liu HB; Gu XL; Ma XQ; Lv TF; Wu Y; Xiao YY; Yuan DM; Li YF; Song Y
Neoplasma; 2013; 60(2):203-8. PubMed ID: 23259790
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic value of thrombocytosis in patients with primary lung cancer].
Pedersen LM; Milman N
Ugeskr Laeger; 1998 Jun; 160(26):3917-20. PubMed ID: 9656833
[TBL] [Abstract][Full Text] [Related]
6. A Temporal Examination of Platelet Counts as a Predictor of Prognosis in Lung, Prostate, and Colon Cancer Patients.
Sylman JL; Boyce HB; Mitrugno A; Tormoen GW; Thomas IC; Wagner TH; Lee JS; Leppert JT; McCarty OJT; Mallick P
Sci Rep; 2018 Apr; 8(1):6564. PubMed ID: 29700384
[TBL] [Abstract][Full Text] [Related]
7. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhang L; Wang C
Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Blood Lymphocytes and Platelets Are Prognostic in Surgical pT1 Non-Small Cell Lung Cancer.
Sulibhavi A; Asokan S; Miller MI; Moreira P; Daly BD; Fernando HC; Litle VR; Suzuki K
Ann Thorac Surg; 2020 Feb; 109(2):337-342. PubMed ID: 31593659
[TBL] [Abstract][Full Text] [Related]
11. Platelet distribution width correlates with prognosis of non-small cell lung cancer.
Cui MM; Li N; Liu X; Yun ZY; Niu Y; Zhang Y; Gao B; Liu T; Wang RT
Sci Rep; 2017 Jun; 7(1):3456. PubMed ID: 28615714
[TBL] [Abstract][Full Text] [Related]
12. Effect of Pretreatment Platelet Parameters on Survival in Limited Disease Small Cell Lung Cancer.
Sakin A; Yasar N; Arici S; Demir C; Geredeli C; Aksaray F; Isik S; Cihan S
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1879-1885. PubMed ID: 31244313
[TBL] [Abstract][Full Text] [Related]
13. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
[TBL] [Abstract][Full Text] [Related]
14. The Value of COX-2, NF-κB, and Blood Routine Indexes in the Prognosis of Malignant Peritoneal Mesothelioma.
Yin W; Zheng G; Su S; Liang Y
Oncol Res Treat; 2019; 42(6):334-341. PubMed ID: 31063993
[TBL] [Abstract][Full Text] [Related]
15. Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection.
Jeong E; Hyun SH; Moon SH; Cho YS; Kim BT; Lee KH
Medicine (Baltimore); 2017 Feb; 96(5):e5935. PubMed ID: 28151879
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
17. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
Rodriguez GC; Clarke-Pearson DL; Soper JT; Berchuck A; Synan I; Dodge RK
Obstet Gynecol; 1994 Mar; 83(3):445-8. PubMed ID: 8127540
[TBL] [Abstract][Full Text] [Related]
18. Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study.
Xu L; Xu F; Kong H; Zhao M; Ye Y; Zhang Y
BMC Cancer; 2020 Nov; 20(1):1152. PubMed ID: 33243184
[TBL] [Abstract][Full Text] [Related]
19. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Values of Platelet-Associated Indicators in Resectable Lung Cancers.
Wang JJ; Wang YL; Ge XX; Xu MD; Chen K; Wu MY; Gong FR; Tao M; Wang WJ; Shou LM; Li W
Technol Cancer Res Treat; 2019 Jan; 18():1533033819837261. PubMed ID: 30871415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
